WILMINGTON, Del. - Monday, 14. July 2025 AETOSWire Print 

Domain control validation sunsets on July 15, 2025, putting many companies that rely on WHOIS email at risk for service disruption

(BUSINESS WIRE)--New research from CSC, an enterprise-class domain security provider and world leader in domain management, SSL management, brand protection, and anti-fraud solutions, indicates that as many as 40% of enterprises are at risk of unexpected service outages caused by out-of-date secure sockets layer (SSL) certificates. This threat stems from the reliance on WHOIS-based email addresses for domain control validation (DCV) that will be officially deprecated on July 15, 2025.

CSC analyzed over 100,000 global SSL certificate records and found that many organizations still use WHOIS email as their primary method for domain control validation, despite a 2024 vote by the CA/ ... Read more »

Investment Will Accelerate PCI’s Leading Position in CDMO, Delivering Life-Changing Therapies to Patients

Transaction Includes Continued Investment from Partners Group

(BUSINESS WIRE) -- PCI Pharma Services (“PCI” or the “Company”), a world-leading global contract development and manufacturing organization (CDMO) focused on innovative biotherapies, today announced that it received a strategic investment co-led by Bain Capital and existing lead investor Kohlberg, and supported with significant reinvestment by Mubadala Investment Company (“Mubadala”). Partners Group will also continue to support the Company with a minority investment. Financial terms of the private transaction were not disclosed.

Headquartered in Philadelphia, Pennsylvania, PCI provides clients with integrated end-to-end drug development, manufacturing and packaging capabilities that increase their products’ speed to market and opportunities for c ... Read more »

Fund Surpassed Hard Cap and Is the Largest Fundraise in the Firm’s History

(BUSINESS WIRE) -- Stone Point Capital LLC, a private equity firm focused on financial services and related industries, today announced the final closing of its tenth private equity fund, Trident X, with $11.5 billion in total commitments. Trident X exceeded its original target and hard cap of $9 billion and is approximately $2.5 billion larger than Trident IX, a $9 billion fund, which closed in 2022.

Trident X received strong support from its existing investor base, as well as first-time commitments from a number of leading institutional investors globally. General Partner and affiliated entities contributed approximately $750 million.

“We are grateful to our limited partners for their continued trust and support, and we are proud of the enduring strength of our Trident Funds over 30 years and many market cycles,” said Chuck Davis, Chairman and Co-Chief Executive Off ... Read more »

OSAKA, Japan & CAMBRIDGE, Mass. - 
– Both Phase 3 Studies Met all Primary and Secondary Endpoints Demonstrating Statistically Significant Improvements Across Symptoms at All Doses, Building Upon Phase 2b Results

– Oveporexton was Generally Well-Tolerated in Phase 3 Safety Profile

– Takeda is Rapidly Advancing Regulatory Submissions and Launch Preparedness with the Aim to Bring Oveporexton to People Living with Narcolepsy Type 1 as Quickly as Possible

– These Results Mark a Major Advancement Toward Transforming the Standard of Care by Addressing the Underlying Cause of Narcolepsy Type 1

(BUSINESS WIRE) -- Takeda (TSE:4502/NYSE:TAK) today announced that all primary and secondary endpoints were met in two Phase 3 randomized, double-blind, placebo-controlled studies of oveporexton (TAK-861), a potential first-in-class investigational oral orexin receptor 2 (OX2R)-selective agonist, in narcolepsy type 1 (NT1). NT1 is ... Read more »

SAN FRANCISCO - Monday, 14. July 2025 AETOSWire Print 

(BUSINESS WIRE) -- Andersen Consulting expands its digital transformation capabilities through a Collaboration Agreement with Baufest, a global digital product design and development firm.

With more 30 years of experience and offices across the Americas and Europe, Baufest is recognized for combining cutting-edge technology with a deep understanding of business strategy and user experience. The firm offers a comprehensive range of services including business design, digital products development, data and applied AI, and cybersecurity. Baufest serves enterprise clients across key industries such as banking and finance, retail, energy, and healthcare, with a focus on driving measurable business outcomes through agile, scalable, and ethical tech practices.

“Our collaboration with Andersen Consulting represents a transformational step forwa ... Read more »

SAINT AUGUSTINE, Fla. - Monday, 14. July 2025 AETOSWire 

(BUSINESS WIRE)--Kihealth, a leader in molecular diagnostics, today announced it has won the Innovation of the Year challenge at the American Diabetes Association’s 85th Scientific Session held in Chicago. Kihealth’s pioneering liquid-biopsy test, which measures the rate of pancreatic beta‑cell death, earned top honors among five finalists for its potential to revolutionize early diabetes detection.

Dubbed the “Super Bowl of diabetes innovation,” this prestigious award has firmly established Kihealth and its products in the spotlight. The honor follows a live pitch to a panel of expert judges and a global audience of clinicians, researchers, and industry leaders. In winning first place, Kihealth stood out for delivering a novel diagnostic that provides patients and clinicians with a critical early window into metabolic health – years before glucose or A1c abnormalities appear ... Read more »

(BUSINESS WIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced the appointment of Dr. Steven R. Cohen, a globally recognized leader in plastic and craniofacial surgery, as Medical Strategy Advisor. His appointment marks a significant step in the company’s strategy to expand its global footprint and enhance its medical excellence.

Dr. Cohen is the Founder of Faces+, an advanced aesthetic and reconstructive surgery center in San Diego, California. With over 30 years of clinical experience, he is widely known for his pioneering work in regenerative aesthetics, including the clinical application of fat-derived stem cells, skeletal facial aesthetic surgery, and the integration of artificial intelligence into medical innovation. Dr. Cohen is also the inventor of the internal craniofacial distraction device ... Read more »